- Rates of metachronous adenoma after curative resection for left-sided or right-sided colon cancer
-
Lam YF, Seto WK, Tong T, Cheung KS, Lo O, Hung IF, Law WL, Leung WK
- KMID: 2434164
- Intest Res.
- 2018 Oct;16(4):619-627.
- doi: 10.5217/ir.2018.00013
BACKGROUND/AIMS: We determined the rates of metachronous colorectal neoplasm in colorectal cancer (CRC) patients after resection for right (R)-sided or left (L)-sided cancer. METHODS: Consecutive CRC patients who had undergone surgical... -
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
-
Cheung KS, Mok CH, Mao X, Zhang R, Hung IF, Seto WK, Yuen MF
- KMID: 2534353
- Clin Mol Hepatol.
- 2022 Oct;28(4):890-911.
- doi: 10.3350/cmh.2022.0087
Background/Aims: Data of coronavirus disease 2019 (COVID-19) vaccine immunogenicity among chronic liver disease (CLD) and liver transplant (LT) patients are conflicting. We performed meta-analysis to examine vaccine immunogenicity regarding etiology,... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
-
Cheung KS, Lam LK, Hui RWH, Mao X, Zhang RR, Chan KH, Hung IF, Seto WK, Yuen MF
- KMID: 2531378
- Clin Mol Hepatol.
- 2022 Jul;28(3):553-564.
- doi: 10.3350/cmh.2022.0082
Background/Aims: Studies of hepatic steatosis (HS) effect on COVID-19 vaccine immunogenicity are lacking. We aimed to compare immunogenicity of BNT162b2 and CoronaVac among moderate/severe HS and control subjects. Methods: Two hundred... -
- CITED
-
- Close
- SHARE
-
- Close
